The panel heard strong support from the company and many doctors but concern from F.D.A. scientists.
Author: PAM BELLUCK
Advertisements
{
"slotId": "6845006044",
"unitType": "responsive",
"resize": "auto"
}F.D.A. Advisers Weigh Allowing First U.S. Over-the-Counter Birth Control Pill